This Viewpoint urges public reporting of percutaneous coronary intervention outcomes to clinicians and health care institutions or publicly report disease states, so physicians would not avoid treating the most seriously ill patients.
This population epidemiology study uses UK clinical database data to investigate trends in prevalence of cardiovascular risk factors and management strategies and their association with trends in mortality among patients with non–ST-elevation myocardial infarction (NSTEMI) between 2003 and 2013.
This secondary analysis of data from the Dual Antiplatelet Therapy (DAPT) trial describes development of a risk prediction tool to identify benefits and harms of continuing thienopyridine therapy after an initial year of treatment following percutaneous coronary intervention.
This randomized trial assesses the long-term clinical outcomes with intravascular ultrasound–guided drug-eluting stent implantation vs those with angiography-guided implantation in Korean patients with long coronary lesions.
This analysis of data from the NCDR CathPCI registry reports that hospital volumes of nonacute percutaneous coronary intervention (PCI), and proportions of PCI classified as inappropriate, have decreased since publication of the Appropriate Use Criteria for Coronary Revascularization.
This Viewpoint summarizes controversies about the findings of clinical trials of revascularization for treatment of stable ischemic heart disease and argues for informing patients about the uncertainties.
You currently have no searches saved.